PetIQ Inc (PETQ)
17.04
+0.20
(+1.19%)
USD |
NASDAQ |
May 03, 16:00
17.02
-0.02
(-0.09%)
After-Hours: 20:00
PetIQ Enterprise Value: 829.40M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 829.40M |
| May 02, 2024 | 823.56M |
| May 01, 2024 | 824.43M |
| April 30, 2024 | 808.37M |
| April 29, 2024 | 811.29M |
| April 26, 2024 | 814.50M |
| April 25, 2024 | 808.37M |
| April 24, 2024 | 814.50M |
| April 23, 2024 | 816.55M |
| April 22, 2024 | 813.92M |
| April 19, 2024 | 807.20M |
| April 18, 2024 | 799.90M |
| April 17, 2024 | 796.98M |
| April 16, 2024 | 804.87M |
| April 15, 2024 | 804.28M |
| April 12, 2024 | 812.46M |
| April 11, 2024 | 837.28M |
| April 10, 2024 | 850.13M |
| April 09, 2024 | 862.10M |
| April 08, 2024 | 864.14M |
| April 05, 2024 | 868.82M |
| April 04, 2024 | 873.78M |
| April 03, 2024 | 878.16M |
| April 02, 2024 | 864.44M |
| April 01, 2024 | 871.74M |
| Date | Value |
|---|---|
| March 28, 2024 | 865.60M |
| March 27, 2024 | 841.08M |
| March 26, 2024 | 851.30M |
| March 25, 2024 | 839.62M |
| March 22, 2024 | 842.24M |
| March 21, 2024 | 845.75M |
| March 20, 2024 | 832.61M |
| March 19, 2024 | 834.36M |
| March 18, 2024 | 786.18M |
| March 15, 2024 | 792.60M |
| March 14, 2024 | 785.89M |
| March 13, 2024 | 815.67M |
| March 12, 2024 | 815.67M |
| March 11, 2024 | 811.58M |
| March 08, 2024 | 808.37M |
| March 07, 2024 | 801.95M |
| March 06, 2024 | 804.28M |
| March 05, 2024 | 815.67M |
| March 04, 2024 | 821.80M |
| March 01, 2024 | 839.03M |
| February 29, 2024 | 863.56M |
| February 28, 2024 | 866.77M |
| February 27, 2024 | 876.99M |
| February 26, 2024 | 867.06M |
| February 23, 2024 | 865.60M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
598.23M
Minimum
Oct 10 2022
1.722B
Maximum
Apr 27 2021
978.41M
Average
926.19M
Median
Oct 17 2023
Enterprise Value Benchmarks
| Dynavax Technologies Corp | 1.014B |
| Pacira BioSciences Inc | 1.509B |
| Supernus Pharmaceuticals Inc | 1.433B |
| Esperion Therapeutics Inc | 564.26M |
| Deciphera Pharmaceuticals Inc | 1.744B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.49M |
| Revenue (Quarterly) | 219.93M |
| Total Expenses (Quarterly) | 218.66M |
| EPS Diluted (Quarterly) | -0.60 |
| Gross Profit Margin (Quarterly) | 20.00% |
| Profit Margin (Quarterly) | -7.95% |
| Earnings Yield | 0.35% |
| Operating Earnings Yield | 10.67% |
| Normalized Earnings Yield | 3.418 |